Pancreatic Cancer Research

ResearcherThe Ohio State University Wexner Medical CenterActive in the last 2 years

Erryk Katayama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2206-8124; OpenAlex author ID A5072169192. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 4 papers · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. Co-author DOI 10.1158/2767-9764.crc-25-0338↗
  2. Association between the Environmental Quality Index and Textbook Outcomes Among Medicare Beneficiaries Undergoing Surgery for Early-Stage Pancreatic Adenocarci… Co-author DOI 10.1007/s11605-023-05757-y↗
  3. Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals. Co-author DOI 10.1245/s10434-023-13230-y↗
  4. Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer. Co-author DOI 10.1002/pon.5945↗
  5. A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems. First author DOI 10.1016/j.surg.2021.10.023↗
  6. Surgical techniques and tips for a reliable murine model of primary and metastatic pancreatic cancer Co-author DOI 10.1101/2022.07.30.502136↗
  7. IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated Depression. Co-author DOI 10.1158/1535-7163.mct-22-0055↗
  8. A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? Co-author DOI 10.18632/oncotarget.27727↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jonathan J. Hue · 6 shared papers, 2020–2026 · strength 0.95
  2. Jordan Michael Winter · 6 shared papers, 2020–2026 · strength 0.95
  3. Ali Vaziri Gohar · 4 shared papers, 2022–2026 · strength 0.69
  4. Mehrdad Zarei · 4 shared papers, 2022–2026 · strength 0.69
  5. Omid Hajihassani · 4 shared papers, 2022–2026 · strength 0.69
  6. Chanza Fahim Shaikh · 2 shared papers, 2023 · strength 0.32
  7. Yutaka Endo · 2 shared papers, 2023 · strength 0.32
  8. Muhammad Musaab Munir · 2 shared papers, 2023 · strength 0.32
  9. Henrique Araujo Lima · 2 shared papers, 2023 · strength 0.32
  10. Zorays Moazzam · 2 shared papers, 2023 · strength 0.32
  11. Timothy Michael Pawlik · 2 shared papers, 2023 · strength 0.32
  12. Luke Daniel Rothermel · 2 shared papers, 2022 · strength 0.27
  13. Mohamedraed Elshami · 2 shared papers, 2022 · strength 0.27
  14. John Brian Ammori · 2 shared papers, 2020–2022 · strength 0.26
  15. David Lawrence Bajor · 2 shared papers, 2020–2022 · strength 0.26
  16. Lee Mayer Ocuin · 2 shared papers, 2020–2022 · strength 0.26
  17. Jeffrey M. Hardacre · 2 shared papers, 2020–2022 · strength 0.26
  18. Lisa M. Coussens · 1 shared paper, 2026 · strength 0.23
  19. Katie E. Blise · 1 shared paper, 2026 · strength 0.23
  20. Sami O. Abul-Khoudoud · 1 shared paper, 2026 · strength 0.23
  21. Robert L Eil · 1 shared paper, 2026 · strength 0.23
  22. Rosalie C. Sears · 1 shared paper, 2026 · strength 0.23
  23. Jonathan Robert Brody · 1 shared paper, 2026 · strength 0.23
  24. Charles D. Lopez · 1 shared paper, 2026 · strength 0.23
  25. Samantha M. Ruff · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.